Recall: Sodium Bicarbonate
Nov. 2022Pharmacy Updates
Exela Pharma Sciences LLC (Exela) has recalled 49 lots of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL vial. This drug is used to treat a condition where there is too much acid in the body fluids. The product is packaged in a 50 mL glass vial. Read the full text of the Sodium Bicarbonate recall.
Recent Announcements
CME Webinar: American Foundation for Suicide Prevention’s ‘Talk Saves Lives’ Program
Please join us on Tuesday, April 28, from noon to 1 p.m. for “Talk Saves Lives: An Introduction to Suicide Prevention.” This live, CME-accredited webinar is the American Foundation for Suicide Prevention’s flagship suicide prevention education program. It covers the scope of this leading cause of death, warning signs and risk factors for suicide, and strategies to prevent it.Feb. 2026Education/Webinars
Training Webinar: Conversio Health COPD Management Program
Please join us for a live training webinar by UPMC Health Plan that will provide an overview of a comprehensive COPD management program from Conversio Health.Jan. 2026Education/Webinars
Provider Directory Updates and Required Attestation
As you know, UPMC Health Plan requires all providers to verify their provider directory information at least every 90 days (quarterly).Jan. 2026Important Notices